Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 2
1978 1
1983 1
1986 2
1987 2
1988 2
1989 2
1990 8
1991 1
1992 6
1993 7
1994 5
1995 12
1996 14
1997 8
1998 14
1999 10
2000 11
2001 12
2002 17
2003 12
2004 12
2005 15
2006 19
2007 18
2008 27
2009 15
2010 29
2011 53
2012 43
2013 68
2014 69
2015 68
2016 43
2017 45
2018 48
2019 56
2020 59
2021 74
2022 73
2023 74
2024 63
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,025 results

Results by year

Filters applied: . Clear all
Page 1
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome.
Gross O, Tönshoff B, Weber LT, Pape L, Latta K, Fehrenbach H, Lange-Sperandio B, Zappel H, Hoyer P, Staude H, König S, John U, Gellermann J, Hoppe B, Galiano M, Hoecker B, Ehren R, Lerch C, Kashtan CE, Harden M, Boeckhaus J, Friede T; German Pediatric Nephrology (GPN) Study Group and EARLY PRO-TECT Alport Investigators. Gross O, et al. Among authors: konig s. Kidney Int. 2020 Jun;97(6):1275-1286. doi: 10.1016/j.kint.2019.12.015. Epub 2020 Jan 17. Kidney Int. 2020. PMID: 32299679 Free article. Clinical Trial.
Comparative Genome Annotation.
König S, Romoth L, Stanke M. König S, et al. Methods Mol Biol. 2018;1704:189-212. doi: 10.1007/978-1-4939-7463-4_6. Methods Mol Biol. 2018. PMID: 29277866 Review.
AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma.
Strecker MI, Wlotzka K, Strassheimer F, Roller B, Ludmirski G, König S, Röder J, Opitz C, Alekseeva T, Reul J, Sevenich L, Tonn T, Wels WS, Steinbach JP, Buchholz CJ, Burger MC. Strecker MI, et al. Among authors: konig s. Oncoimmunology. 2022 Oct 11;11(1):2127508. doi: 10.1080/2162402X.2022.2127508. eCollection 2022. Oncoimmunology. 2022. PMID: 36249274 Free PMC article.
Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clustering.
Nelke C, Schroeter CB, Barman S, Stascheit F, Masanneck L, Theissen L, Huntemann N, Walli S, Cengiz D, Dobelmann V, Vogelsang A, Pawlitzki M, Räuber S, Konen FF, Skripuletz T, Hartung HP, König S, Roos A, Meisel A, Meuth SG, Ruck T. Nelke C, et al. Among authors: konig s. EBioMedicine. 2024 Jul;105:105231. doi: 10.1016/j.ebiom.2024.105231. Epub 2024 Jul 2. EBioMedicine. 2024. PMID: 38959848 Free PMC article.
Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravis.
Schroeter CB, Nelke C, Stascheit F, Huntemann N, Preusse C, Dobelmann V, Theissen L, Pawlitzki M, Räuber S, Willison A, Vogelsang A, Marina AD, Hartung HP, Melzer N, Konen FF, Skripuletz T, Hentschel A, König S, Schweizer M, Stühler K, Poschmann G, Roos A, Stenzel W, Meisel A, Meuth SG, Ruck T. Schroeter CB, et al. Among authors: konig s. Acta Neuropathol. 2024 Jun 18;147(1):102. doi: 10.1007/s00401-024-02754-6. Acta Neuropathol. 2024. PMID: 38888758 Free PMC article.
Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatment.
Lu IN, Cheung PF, Heming M, Thomas C, Giglio G, Leo M, Erdemir M, Wirth T, König S, Dambietz CA, Schroeter CB, Nelke C, Siveke JT, Ruck T, Klotz L, Haider C, Höftberger R, Kleinschnitz C, Wiendl H, Hagenacker T, Meyer Zu Horste G. Lu IN, et al. Among authors: konig s. Nat Commun. 2024 May 15;15(1):4120. doi: 10.1038/s41467-024-48195-3. Nat Commun. 2024. PMID: 38750052 Free PMC article.
Observations from the Proteomics Bench.
König S, Schork K, Eisenacher M. König S, et al. Proteomes. 2024 Feb 6;12(1):6. doi: 10.3390/proteomes12010006. Proteomes. 2024. PMID: 38390966 Free PMC article.
1,025 results